H&R GMBH & CO KGAA (2HRA.DE) Stock Fundamental Analysis
Europe - Frankfurt Stock Exchange - FRA:2HRA - DE000A2E4T77 - Common Stock
4.75 EUR
+0.07 (+1.5%)
Overall 2HRA gets a fundamental rating of 3 out of 10. We evaluated 2HRA against 72 industry peers in the Chemicals industry. There are concerns on the financial health of 2HRA while its profitability can be described as average. 2HRA does not seem to be growing, but still is valued expensively.
1. Profitability
1.1 Basic Checks
In the past year 2HRA was profitable.
2HRA had a positive operating cash flow in the past year.
2HRA had positive earnings in 4 of the past 5 years.
Each year in the past 5 years 2HRA had a positive operating cash flow.
1.2 Ratios
2HRA has a Return On Assets of 0.40%. This is comparable to the rest of the industry: 2HRA outperforms 41.10% of its industry peers.
2HRA has a Return On Equity (0.95%) which is comparable to the rest of the industry.
2HRA has a Return On Invested Capital (2.43%) which is comparable to the rest of the industry.
Measured over the past 3 years, the Average Return On Invested Capital for 2HRA is below the industry average of 7.08%.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 0.4% | ||
| ROE | 0.95% | ||
| ROIC | 2.43% |
ROA(3y)2.22%
ROA(5y)2.24%
ROE(3y)5.04%
ROE(5y)5.21%
ROIC(3y)4.21%
ROIC(5y)4.11%
1.3 Margins
The Profit Margin of 2HRA (0.31%) is worse than 60.27% of its industry peers.
In the last couple of years the Profit Margin of 2HRA has declined.
The Operating Margin of 2HRA (2.18%) is worse than 64.38% of its industry peers.
2HRA's Operating Margin has improved in the last couple of years.
Looking at the Gross Margin, with a value of 24.46%, 2HRA is doing worse than 67.12% of the companies in the same industry.
2HRA's Gross Margin has improved in the last couple of years.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 2.18% | ||
| PM (TTM) | 0.31% | ||
| GM | 24.46% |
OM growth 3Y-26.17%
OM growth 5Y25.85%
PM growth 3Y-42.71%
PM growth 5YN/A
GM growth 3Y-4.08%
GM growth 5Y2.14%
2. Health
2.1 Basic Checks
With a Return on Invested Capital (ROIC) below the Cost of Capital (WACC), 2HRA is destroying value.
The number of shares outstanding for 2HRA remains at a similar level compared to 1 year ago.
2HRA has about the same amout of shares outstanding than it did 5 years ago.
2HRA has a better debt/assets ratio than last year.
2.2 Solvency
An Altman-Z score of 2.13 indicates that 2HRA is not a great score, but indicates only limited risk for bankruptcy at the moment.
2HRA has a Altman-Z score of 2.13. This is comparable to the rest of the industry: 2HRA outperforms 42.47% of its industry peers.
2HRA has a debt to FCF ratio of 33.63. This is a negative value and a sign of low solvency as 2HRA would need 33.63 years to pay back of all of its debts.
The Debt to FCF ratio of 2HRA (33.63) is comparable to the rest of the industry.
A Debt/Equity ratio of 0.13 indicates that 2HRA is not too dependend on debt financing.
Looking at the Debt to Equity ratio, with a value of 0.13, 2HRA is in the better half of the industry, outperforming 78.08% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.13 | ||
| Debt/FCF | 33.63 | ||
| Altman-Z | 2.13 |
ROIC/WACC0.44
WACC5.51%
2.3 Liquidity
2HRA has a Current Ratio of 1.42. This is a normal value and indicates that 2HRA is financially healthy and should not expect problems in meeting its short term obligations.
Looking at the Current ratio, with a value of 1.42, 2HRA is doing worse than 65.75% of the companies in the same industry.
2HRA has a Quick Ratio of 1.42. This is a bad value and indicates that 2HRA is not financially healthy enough and could expect problems in meeting its short term obligations.
2HRA's Quick ratio of 0.75 is on the low side compared to the rest of the industry. 2HRA is outperformed by 75.34% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 1.42 | ||
| Quick Ratio | 0.75 |
3. Growth
3.1 Past
2HRA shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -30.03%.
2HRA shows a very negative growth in Earnings Per Share. Measured over the last years, the EPS has been decreasing by -40.40% yearly.
The Revenue has decreased by -3.07% in the past year.
2HRA shows a small growth in Revenue. Measured over the last years, the Revenue has been growing by 4.47% yearly.
EPS 1Y (TTM)-30.03%
EPS 3Y-40.4%
EPS 5YN/A
EPS Q2Q%-122.22%
Revenue 1Y (TTM)-3.07%
Revenue growth 3Y4.04%
Revenue growth 5Y4.47%
Sales Q2Q%-8.14%
3.2 Future
Based on estimates for the next years, 2HRA will show a small growth in Earnings Per Share. The EPS will grow by 2.54% on average per year.
Based on estimates for the next years, 2HRA will show a decrease in Revenue. The Revenue will decrease by -0.27% on average per year.
EPS Next Y-64.54%
EPS Next 2Y-9.3%
EPS Next 3Y2.54%
EPS Next 5YN/A
Revenue Next Year-4.97%
Revenue Next 2Y-1.66%
Revenue Next 3Y-0.27%
Revenue Next 5YN/A
3.3 Evolution
When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.
4. Valuation
4.1 Price/Earnings Ratio
The Price/Earnings ratio is 47.50, which means the current valuation is very expensive for 2HRA.
Compared to the rest of the industry, the Price/Earnings ratio of 2HRA indicates a slightly more expensive valuation: 2HRA is more expensive than 63.01% of the companies listed in the same industry.
When comparing the Price/Earnings ratio of 2HRA to the average of the S&P500 Index (26.54), we can say 2HRA is valued expensively.
2HRA is valuated rather expensively with a Price/Forward Earnings ratio of 24.09.
Based on the Price/Forward Earnings ratio, 2HRA is valued a bit more expensive than 65.75% of the companies in the same industry.
When comparing the Price/Forward Earnings ratio of 2HRA to the average of the S&P500 Index (23.78), we can say 2HRA is valued inline with the index average.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 47.5 | ||
| Fwd PE | 24.09 |
4.2 Price Multiples
100.00% of the companies in the same industry are more expensive than 2HRA, based on the Enterprise Value to EBITDA ratio.
Compared to the rest of the industry, the Price/Free Cash Flow ratio of 2HRA is on the same level as its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 36.95 | ||
| EV/EBITDA | 2.74 |
4.3 Compensation for Growth
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y-9.3%
EPS Next 3Y2.54%
5. Dividend
5.1 Amount
With a Yearly Dividend Yield of 2.14%, 2HRA has a reasonable but not impressive dividend return.
2HRA's Dividend Yield is comparable with the industry average which is at 2.81.
Compared to an average S&P500 Dividend Yield of 1.96, 2HRA has a dividend comparable with the average S&P500 company.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 2.14% |
5.2 History
Dividend Growth(5Y)N/A
Div Incr Years0
Div Non Decr Years2
5.3 Sustainability
94.56% of the earnings are spent on dividend by 2HRA. This is not a sustainable payout ratio.
DP94.56%
EPS Next 2Y-9.3%
EPS Next 3Y2.54%
FRA:2HRA (12/12/2025, 7:00:00 PM)
4.75
+0.07 (+1.5%)
Chartmill FA Rating
GICS SectorMaterials
GICS IndustryGroupMaterials
GICS IndustryChemicals
Earnings (Last)
Earnings (Next)
Inst Owners2.05%
Inst Owner ChangeN/A
Ins Owners6.06%
Ins Owner ChangeN/A
Market Cap176.79M
Revenue(TTM)1.29B
Net Income(TTM)3.94M
Analysts40
Price Target5.03 (5.89%)
Short Float %N/A
Short RatioN/A
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 2.14% |
Yearly Dividend0.1
Dividend Growth(5Y)N/A
DP94.56%
Div Incr Years0
Div Non Decr Years2
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)-1.33%
PT rev (3m)-1.33%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)-44.45%
EPS NY rev (3m)-57.27%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)-0.46%
Revenue NY rev (3m)-1.52%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 47.5 | ||
| Fwd PE | 24.09 | ||
| P/S | 0.14 | ||
| P/FCF | 36.95 | ||
| P/OCF | 2.7 | ||
| P/B | 0.43 | ||
| P/tB | 0.46 | ||
| EV/EBITDA | 2.74 |
EPS(TTM)0.1
EY2.11%
EPS(NY)0.2
Fwd EY4.15%
FCF(TTM)0.13
FCFY2.71%
OCF(TTM)1.76
OCFY36.97%
SpS34.61
BVpS11.09
TBVpS10.33
PEG (NY)N/A
PEG (5Y)N/A
Graham Number5
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 0.4% | ||
| ROE | 0.95% | ||
| ROCE | 4.1% | ||
| ROIC | 2.43% | ||
| ROICexc | 2.75% | ||
| ROICexgc | 2.88% | ||
| OM | 2.18% | ||
| PM (TTM) | 0.31% | ||
| GM | 24.46% | ||
| FCFM | 0.37% |
ROA(3y)2.22%
ROA(5y)2.24%
ROE(3y)5.04%
ROE(5y)5.21%
ROIC(3y)4.21%
ROIC(5y)4.11%
ROICexc(3y)4.64%
ROICexc(5y)4.53%
ROICexgc(3y)4.9%
ROICexgc(5y)4.79%
ROCE(3y)7.11%
ROCE(5y)6.95%
ROICexgc growth 3Y-25.59%
ROICexgc growth 5Y22.95%
ROICexc growth 3Y-25.37%
ROICexc growth 5Y23.82%
OM growth 3Y-26.17%
OM growth 5Y25.85%
PM growth 3Y-42.71%
PM growth 5YN/A
GM growth 3Y-4.08%
GM growth 5Y2.14%
F-Score5
Asset Turnover1.31
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.13 | ||
| Debt/FCF | 33.63 | ||
| Debt/EBITDA | 0.59 | ||
| Cap/Depr | 98.21% | ||
| Cap/Sales | 4.7% | ||
| Interest Coverage | 3.72 | ||
| Cash Conversion | 72.84% | ||
| Profit Quality | 121.57% | ||
| Current Ratio | 1.42 | ||
| Quick Ratio | 0.75 | ||
| Altman-Z | 2.13 |
F-Score5
WACC5.51%
ROIC/WACC0.44
Cap/Depr(3y)102.18%
Cap/Depr(5y)93.34%
Cap/Sales(3y)4.27%
Cap/Sales(5y)4.26%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-30.03%
EPS 3Y-40.4%
EPS 5YN/A
EPS Q2Q%-122.22%
EPS Next Y-64.54%
EPS Next 2Y-9.3%
EPS Next 3Y2.54%
EPS Next 5YN/A
Revenue 1Y (TTM)-3.07%
Revenue growth 3Y4.04%
Revenue growth 5Y4.47%
Sales Q2Q%-8.14%
Revenue Next Year-4.97%
Revenue Next 2Y-1.66%
Revenue Next 3Y-0.27%
Revenue Next 5YN/A
EBIT growth 1Y3.84%
EBIT growth 3Y-23.19%
EBIT growth 5Y31.47%
EBIT Next Year170.83%
EBIT Next 3Y44.32%
EBIT Next 5YN/A
FCF growth 1Y-94.25%
FCF growth 3YN/A
FCF growth 5Y-5.95%
OCF growth 1Y-56.02%
OCF growth 3Y23.36%
OCF growth 5Y-6.03%
H&R GMBH & CO KGAA / 2HRA.DE FAQ
Can you provide the ChartMill fundamental rating for H&R GMBH & CO KGAA?
ChartMill assigns a fundamental rating of 3 / 10 to 2HRA.DE.
Can you provide the valuation status for H&R GMBH & CO KGAA?
ChartMill assigns a valuation rating of 2 / 10 to H&R GMBH & CO KGAA (2HRA.DE). This can be considered as Overvalued.
Can you provide the profitability details for H&R GMBH & CO KGAA?
H&R GMBH & CO KGAA (2HRA.DE) has a profitability rating of 4 / 10.
How financially healthy is H&R GMBH & CO KGAA?
The financial health rating of H&R GMBH & CO KGAA (2HRA.DE) is 3 / 10.
What is the expected EPS growth for H&R GMBH & CO KGAA (2HRA.DE) stock?
The Earnings per Share (EPS) of H&R GMBH & CO KGAA (2HRA.DE) is expected to decline by -64.54% in the next year.